Prepaid expenses and deposits 933,299 372,548
Total current assets 16,277,715 14,411,124
Due from related parties 2,630,019 1,976,815
Property and equipments, net 26,275,871 13,673,067
Intangible assets, net 6,359,000 1,501,483
Goodwill 7,395,752 --
Restricted cash 3,957,624 --
Other assets 1,710,972 --
Debt issue costs 327,945 --
Total Assets $64,934,898 $31,562,489
Liabilities & Shareholders' Equity
Current Liabilities
Bank indebtedness $874,490 $--
Bank loans payable (current portion) 2,867,004 256,492
Long-term debt payable (current
portion) 1,787,239 --
Accounts payable and accrued
liabilities 4,665,984 1,823,030
Commercial notes payable 5,118,758 --
Taxes payable 1,279,385 226,931
Acquisition price payable 1,333,246 --
Wages payable 664,786 145,903
Deferred revenues -- 1,732
Total current liabilities 18,590,892 2,454,088
Long-term debt payable (long term
portion) 425,001 --
Long-term convertible promissory
notes 2,875,075 --
Due to related parties (Long-term) 3,193,618 3,034,365
Total li
'/>"/>
| SOURCE Benda Pharmaceutical, Inc. Copyright©2008 PR Newswire. All rights reserved |